Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 165

Sort by

Sort Order Select

Journal Articles

Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution. Results from the BMT CTN 1801 study.

Blood (2025) 146 (Supplement 1): 4198.

https://doi.org/10.1182/blood-2025-4198

Published: 2025

Journal Articles

Systematic molecular profiling to identify determinants of response to ibrutinib

Blood (2025) 146 (Supplement 1): 3881.

https://doi.org/10.1182/blood-2025-3881

Published: 2025

Journal Articles

Pre-existing cytotoxic capacity of CD8+ and CD4+ T cells is a hallmark of richter transformation and favors response to anti-PD-1 therapy

Blood (2025) 146 (Supplement 1): 243.

https://doi.org/10.1182/blood-2025-243

Published: 2025

Journal Articles

Murine modeling of cluster 1 diffuse large B-cell lymphoma reveals transformation from marginal zone lymphoma

Tianfang Ma, Elisa Mandato, Filip Garbicz, Yifei Gao, Arsh Patel, Eleonora Calabretta, Julia Paczkowska, Yanbo Sun, Billie Porter, Zhe Wang, Jutatip Panaampon, Sumbul Khan, Donna Neuberg, Baochun Zhang, Scott Rodig, Suzan Lazo, Ruben Carrasco, Li Song, Margaret Shipp

Blood (2025) 146 (Supplement 1): 1478.

https://doi.org/10.1182/blood-2025-1478

Published: 2025

Journal Articles

Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001

Melissa Burns, Yael Flamand, Lynda Vrooman, Victoria Koch, Sarah Cronholm, Sarah Hunt, Marian Harris, Peter Cole, Lisa Gennarini, Nobuko Hijiya, Justine Kahn, Kara Kelly, Bruno Michon, Donna Neuberg, Andrew Place, Thai Tran, Jennifer Welch, Stephen Sallan, Lewis Silverman

Blood (2025) 146 (Supplement 1): 644.

https://doi.org/10.1182/blood-2025-644

Published: 2025

Journal Articles

Longer telomeres in donors aged ≥35 years reduce graft failure and non-relapse mortality after allogeneic HCT

Nico Gagelmann, Kyle Hebert, Thomas McGovern, Gabrielle Schmidt, Valerie Stewart, Donna Neuberg, Stephen Spellman, Jeffery Auletta, Steven Devine, Robert Soiffer, Immaculata De Vivo, Christopher Reilly, R. Coleman Lindsley

Blood (2025) 146 (Supplement 1): 373.

https://doi.org/10.1182/blood-2025-373

Published: 2025

Journal Articles

HLA mismatch-derived epitopes predict acute graft-versus-host disease risk after unrelated donor transplantation

Nicoletta Cieri, Yiren Shao, Luis Correa-Medero, Julia Keating, Meilun He, Yung-Tsi Bolon, Griffin Lawrence, Jerome Ritz, Robert Soiffer, Jenn Abelin, Donna Neuberg, Stephen Spellman, Catherine Wu

Blood (2025) 146 (Supplement 1): 4249.

https://doi.org/10.1182/blood-2025-4249

Published: 2025

Journal Articles

Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations

Blood (2025) 146 (Supplement 1): 8.

https://doi.org/10.1182/blood-2025-8

Published: 2025

Journal Articles

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Blood (2025) 146 (Supplement 1): 6.

https://doi.org/10.1182/blood-2025-6

Published: 2025

Journal Articles

Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826

Blood (2025) 146 (Supplement 1): 351.

https://doi.org/10.1182/blood-2025-351

Published: 2025

Journal Articles

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

Rebecca L. Zon, Aswin Sekar, Katharine Clapham, Ohad Oren, Abhishek Niroula, Alexander G. Bick, Christopher J. Gibson, Gabriel Griffin, Md Mesbah Uddin, Donna Neuberg, Pradeep Natarajan, Benjamin L. Ebert

Blood (2024) 144 (20): 2149–2154.

https://doi.org/10.1182/blood.2024024187

Published: 2024

Includes: Supplemental data

Journal Articles

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Blood (2023) 141 (15): 1884–1888.

https://doi.org/10.1182/blood.2022017686

Published: 2023

Includes: Supplemental data

Journal Articles

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19

Blood (2022) 140 (18): 1993–1997.

https://doi.org/10.1182/blood.2022018052

Published: 2022

Includes: Supplemental data

Journal Articles

TET2 -mutant clonal hematopoiesis and risk of gout

Blood (2022) 140 (10): 1094–1103.

https://doi.org/10.1182/blood.2022015384

Published: 2022

Includes: Supplemental data

Journal Articles

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Peter G. Miller, Dandi Qiao, Joselyn Rojas-Quintero, Michael C. Honigberg, Adam S. Sperling, Christopher J. Gibson, Alexander G. Bick, Abhishek Niroula, Marie E. McConkey, Brittany Sandoval, Brian C. Miller, Weiwei Shi, Kaushik Viswanathan, Matthew Leventhal, Lillian Werner, Matthew Moll, Brian E. Cade, R. Graham Barr, Adolfo Correa, L. Adrienne Cupples, Sina A. Gharib, Deepti Jain, Stephanie M. Gogarten, Leslie A. Lange, Stephanie J. London, Ani Manichaikul, George T. O’Connor, Elizabeth C. Oelsner, Susan Redline, Stephen S. Rich, Jerome I. Rotter, Vasan Ramachandran, Bing Yu, Lynette Sholl, Donna Neuberg, Siddhartha Jaiswal, Bruce D. Levy, Caroline A. Owen, Pradeep Natarajan, Edwin K. Silverman, Peter van Galen, Yohannes Tesfaigzi, Michael H. Cho, Benjamin L. Ebert, for the COPDGene Study Investigators, National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine Consortium

Blood (2022) 139 (3): 357–368.

https://doi.org/10.1182/blood.2021013531

Published: 2022

Includes: Supplemental data

Journal Articles

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Blood (2021) 138 (10): 898–911.

https://doi.org/10.1182/blood.2021011075

Published: 2021

Includes: Supplemental data

Journal Articles

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Blood (2021) 137 (23): 3212–3217.

https://doi.org/10.1182/blood.2021010867

Published: 2021

Includes: Supplemental data

Journal Articles

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Blood (2021) 137 (10): 1353–1364.

https://doi.org/10.1182/blood.2020006464

Published: 2021

Includes: Supplemental data

Journal Articles

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Mikko Myllymäki, Robert Redd, Christopher R. Reilly, Wael Saber, Stephen R. Spellman, Christopher J. Gibson, Zhen-Huan Hu, Tao Wang, Esther H. Orr, Jaclyn G. Grenier, Maxine M. Chen, David P. Steensma, Corey Cutler, Immaculata De Vivo, Joseph H. Antin, Donna Neuberg, Suneet Agarwal, R. Coleman Lindsley

Blood (2020) 136 (26): 3070–3081.

https://doi.org/10.1182/blood.2020005397

Published: 2020

Includes: Supplemental data

Journal Articles

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Blood (2020) 136 (Supplement 1): 15–17.

https://doi.org/10.1182/blood-2020-136235

Published: 2020

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution. Results from the BMT CTN 1801 study.

Systematic molecular profiling to identify determinants of response to ibrutinib

Pre-existing cytotoxic capacity of CD8+ and CD4+ T cells is a hallmark of richter transformation and favors response to anti-PD-1 therapy

Murine modeling of cluster 1 diffuse large B-cell lymphoma reveals transformation from marginal zone lymphoma

Outcome of children and adolescents with newly diagnosed T-cell acute lymphoblastic leukemia: Results of DFCI ALL consortium protocol 16-001

Longer telomeres in donors aged ≥35 years reduce graft failure and non-relapse mortality after allogeneic HCT

HLA mismatch-derived epitopes predict acute graft-versus-host disease risk after unrelated donor transplantation

Sickle cell disease is associated with early-onset clonal hematopoiesis involving DNA damage response pathway mutations

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826

JAK2 -mutant clonal hematopoiesis is associated with venous thromboembolism

Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19

TET2 -mutant clonal hematopoiesis and risk of gout

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Safety and Efficacy of Decitabine Plus Ipilimumab in Relapsed or Refractory MDS/AML in the Post-BMT or Transplant Naïve Settings

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only